Moreover, if in certain pathologies, e.g., sJIA, high IL-18 levels are detected early enough, it may prevent progression to MAS (Canna & Marsh, 2020) (Krei et al., 2021) [57,58]. This evidence concerns the gene IL18 and systemic-onset juvenile idiopathic arthritis.